Patents by Inventor Ann Charlotte Birgit Johansson

Ann Charlotte Birgit Johansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systemic administration of a therapeutic preparation
    Patent number: 6846801
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: January 25, 2005
    Assignee: AstraZeneca AB
    Inventors: Kjell Göran Erik Bäckström, Carl Magnus Olof Dahlbäck, Peter Edman, Ann Charlotte Birgit Johansson
  • Compositions for inhalation
    Patent number: 6794357
    Abstract: Disclosed herein are dry powder compositions comprising a pharmacologically active polypeptide and a surfactant, wherein at least 50% of the total mass of the polypeptide and the surfactant consists of primary particles having a diameter less than 10 microns. The compositions are suitable for inhalation from a dry powder inhaler device.
    Type: Grant
    Filed: October 24, 1996
    Date of Patent: September 21, 2004
    Assignee: AstraZeneca AB
    Inventors: Kjell Göran Erik Bäckström, Carl Magnus Olof Dahlbäck, Peter Edman, Ann Charlotte Birgit Johansson
  • Compositions for inhalation
    Publication number: 20040171550
    Abstract: A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.
    Type: Application
    Filed: March 3, 2004
    Publication date: September 2, 2004
    Applicant: AstraZeneca AB, a Swedish corporation
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Systemic administration of a therapeutic preparation
    Publication number: 20030216541
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Application
    Filed: March 27, 2003
    Publication date: November 20, 2003
    Applicant: AstraZeneca AB, a Swedish corporation
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Systemic administration of a therapeutic preparation
    Publication number: 20030211972
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Application
    Filed: March 27, 2003
    Publication date: November 13, 2003
    Applicant: AstraZeneca AB, a Sweden corporation
    Inventors: Kjell Goran Erik Backstrom, Carlos Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Compositions for inhalation
    Patent number: 6632456
    Abstract: A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: October 14, 2003
    Assignee: AstraZeneca AB
    Inventors: Kjell Göran Erik Bäckström, Carl Magnus Olof Dahlbäck, Peter Edman, Ann Charlotte Birgit Johansson
  • Therapeutic preparation for inhalation
    Patent number: 6610653
    Abstract: A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: August 26, 2003
    Assignee: AstraZeneca AB
    Inventors: Kjell Göran Erik Bäckström, Carl Magnus Olof Dahlbäck, Peter Edman, Ann Charlotte Birgit Johansson
  • Therapeutic preparation for inhalation
    Patent number: 6306440
    Abstract: A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: October 23, 2001
    Assignee: AstraZeneca AB
    Inventors: Kjell Göran Erik Bäckström, Carl Magnus Olof Dahlbäck, Peter Edman, Ann Charlotte Birgit Johansson
  • Systemic administration of a therapeutic preparation
    Publication number: 20010025037
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Application
    Filed: February 14, 2001
    Publication date: September 27, 2001
    Applicant: AstraZeneca AB
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Systemic administration of a therapeutic preparation
    Publication number: 20010003739
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Application
    Filed: December 6, 2000
    Publication date: June 14, 2001
    Applicant: AstraZeneca AB
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Therapeutic preparation for inhalation
    Patent number: 6165976
    Abstract: A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: December 26, 2000
    Assignee: Astra Aktiebolag
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Processes for preparing compositions for inhalation
    Patent number: 5952008
    Abstract: A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: September 14, 1999
    Assignee: AB Astra
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Systemic administration of a therapeutic preparation
    Patent number: 5830853
    Abstract: A method of treating a patient in need of insulin treatment, including the steps of introducing into the lower respiratory tract of the patient an effective amount of a therapeutic preparation in the form of a dry powder containing (a) insulin and (b) an enhancer compound which enhances the absorption of insulin in the lungs of the patient.
    Type: Grant
    Filed: January 4, 1996
    Date of Patent: November 3, 1998
    Assignee: Astra Aktiebolag
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Therapeutic preparation for inhalation
    Patent number: 5747445
    Abstract: A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
    Type: Grant
    Filed: January 4, 1996
    Date of Patent: May 5, 1998
    Assignee: Astra Aktiebolag
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson
  • Therapeutic preparation for inhalation
    Patent number: 5658878
    Abstract: A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 19, 1997
    Assignee: AB Astra
    Inventors: Kjell Goran Erik Backstrom, Carl Magnus Olof Dahlback, Peter Edman, Ann Charlotte Birgit Johansson